CLINICAL_TRIALS
trial_result
· 2024-07-25
Clinical Trial Update: A Study of MK-8189 in Participants With Schizophrenia (MK-8189-014) [Phase 1]
Summary
A Phase 1 study of MK-8189 in participants with schizophrenia has completed, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2024-07-25